Know Labs Completes Build of Portable Generation 1 Prototype for Non-Invasive Glucose Monitoring

SEATTLE–(BUSINESS WIRE)–Know Labs (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, revealed the next stage in the development of its proprietary Bio-RFID™ technology – the Generation (Gen) 1 Device. Gen 1 incorporates Know Labs’ Bio-RFID sensor – which has been proven as technically feasible and stable in delivering repeatable results in measuring blood glucose when used in a lab environment – in a portable device. Currently, there are no medical-grad
Click here to view original post